Controlled trials show no clear benefit of inhaled opioids over oral or i.v. administration in the treatment of dyspnea. Low-dose oral or sublingual opioids are effective in treating dyspnea.

[1] While therapies for the treatment of dyspnea in end-stage CF lung disease are limited, case reports of its effective treatment with inhaled opioids have been published. However, the use of ...